Sector Investors News and Insights

NVAX

ETFsector.com Daily Trading Outlook

May 20, 2025 S&P futures are down 0.3% Tuesday morning after US equities reversed early losses Monday, with the S&P recovering from a 1% drop to close slightly higher. Healthcare outperformed while energy lagged. Asian markets were mostly higher, led by Hong Kong (+1.5%), while European markets edged up ~0.2%. Treasuries are slightly firmer, the […]

ETFsector.com Daily Trading Outlook Read More »

, , , , , , , , , , , , , , , , , ,

ETFsector.com Daily Trading Outlook

May 19, 2025 S&P 500 futures are down 1.1% in early Monday trading after a strong rally last week, where the index climbed over 5%, leaving it up 19.5% from April lows and over 1% YTD. Tariff-exposed, most-shorted stocks, big tech, and semiconductors led the recent charge. Global markets are softer: Asian indices were mixed

ETFsector.com Daily Trading Outlook Read More »

, , , , , , , ,

Morning Brew reports on NIO’s revenue decline, Novavax’s gains in response to FDA review, and GSK’s acquisition of Elsie Biotech.

Stocks that are related include AAPL, NVAX, NIO, GSK, NVDA, MSFT, VNDA, IREN, MCRB, SMG, CORZ, with a 0.6% increase in HONGKONG’S HANG SENG.

Morning Brew reports on NIO’s revenue decline, Novavax’s gains in response to FDA review, and GSK’s acquisition of Elsie Biotech. Read More »

, , , ,

Morning Brew summarizes the latest news: NIO has reported a decrease in revenue, Novavax’s stock price is up following an FDA review, and GSK announces the acquisition of Elsie Biotech.

Stocks that are related include AAPL, NVAX, NIO, GSK, NVDA, MSFT, VNDA, IREN, MCRB, SMG, and CORZ, with a 0.6% increase in HONGKONG’S HANGSENG.

Morning Brew summarizes the latest news: NIO has reported a decrease in revenue, Novavax’s stock price is up following an FDA review, and GSK announces the acquisition of Elsie Biotech. Read More »

, , , ,
Scroll to Top

Subscribe to our Newsletter

Stay updated with the latests analysis and insights fromm etfsector.com

If you haven’t received your newsletter email, check your spam/junk folder and add us to your contacts to ensure delivery.